None

Gainers Plus Therapeutics, Inc. (NASDAQ: PSTV) shares rose 88.7% to $1.04 in pre-market trading after the company was awarded $17.6 million from State of Texas for continued development of co.'s lead investigational targeted radiotherapeutic Rhenium-186 NanoLiposome for the treatment of patients with leptomeningeal metastases. Codiak BioSciences, Inc. (NASDAQ: CDAK) shares rose 42.4% to $3.29 in pre-market trading. Codiak BioSciences recently posted a Q2 loss of $0.30 per share. Wolfspeed, Inc. (NYSE: WOLF) rose 20.7% to $103.40 in pre-market trading after the company reported better-than-expected Q4 results. Vinco Ventures, Inc. (NASDAQ: BBIG) rose 16.6% to $1.62 in pre-market trading after jumping 23% on Wednesday. bluebird bio, Inc. (NASDAQ: BLUE) shares rose 13.5% to $7.70 in pre-market trading. The FDA has approved Bluebird bio’s Zynteglo (betibeglogene autotemcel), also known as beti-cel, a one-time gene therapy custom-designed for beta‑thalassemia. Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) rose 13.1% to $0.2425 in pre-market trading after declining 12% on Wednesday. Corbus Pharmaceuticals recently posted a Q2 loss of $0.11 per share. Applied DNA Sciences, Inc. (NASDAQ: APDN) rose 12.9% to $4.19 in pre-market trading after climbing 11% on Wednesday. Applied DNA Sciences recently posted a Q3 loss of $0.13 per share. Endo International plc (NASDAQ: ENDP) rose 10.2% to $0.3128 in pre-market trading after dipping 23% on Wednesday. Endo International filed for bankruptcy after reaching a $6 billion deal with some of its creditors as the company sought to settle opioid-related lawsuits. Privia Health Group, Inc. (NASDAQ: PRVA) rose 9.7% to $39.40 in pre-market trading. Privia ...

Related tickers: BBBY, HUT, CSCO, UBX, ENDP, GRIN, KIRK, VERB, WOLF, CDAK, CDR, PSTV, APDN, PSHG, BWV, JUPW, TLSA, BBIG, FNHC, PALI, BLUE, PRVA, FATE, MNMD, RARE, VCSA, CRBP, KEYS, PETZ.

CALGARY, Alberta, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Condor Energies Inc. (“Condor” or the “Company”) (TSX: CPI), a Canadian based energy company with activities in Turkiye and Kazakhstan, is pleased to announce the release of its unaudited interim condensed consolidated financial statements for the three and six months ended June 30, 2022 together with the related management’s discussion and analysis. These documents will be made available under Condor’s profile on SEDAR at www.sedar.com and on the Condor website at www.condorenergies.ca. Readers are invited to review the latest corporate presentation available on the Condor website. All financial amounts in this news release are presented in Canadian dollars, unless otherwise stated.

Related tickers: CDR, CPI.